Moderna faces a patent infringement hearing today, September 1. The hearing is at the Unified Patent Court's local division in The Hague.
GlaxoSmithKline (GSK) filed the lawsuit. GSK alleges Moderna's mRNA vaccines infringe its patents.
Judge Edger Brinkman presides over the case. This case is part of ongoing legal battles among pharmaceutical giants over mRNA vaccine technology.
A parallel hearing is scheduled for September 3. This hearing involves GSK against Pfizer and BioNTech on similar grounds.
The specific patent concerns liposomes used for RNA delivery. This patent is central to both proceedings.
These hearings represent the next major showdown in Europe's largest mRNA patent disputes. The Hague emerges as a key venue for pharmaceutical litigation.